These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results

Boston Scientific Corp (NYSE:BSX) on Wednesday posted upbeat third-quarter financial results and cut its FY26 guidance below estimates.

Benzinga • 15 hours ago

Boston Scientific Q3 Earnings Call Highlights

Boston Scientific NYSE: BSX reported third-quarter 2026 results that fell below its prior guidance after a cybersecurity incident disrupted manufacturing and product shipments for eight business days, while competitive and pricing pressures weighed on key cardiovascular franchises.

MarketBeat • 20 hours ago

BSX Q3 Earnings Call Flags Growth Challenges Through 2027

Boston Scientific faces a challenging 2027 as cybersecurity disruptions, EP and WATCHMAN weakness and China pricing pressures weigh on growth prospects.

Zacks Investment Research • 11 hours ago

Penumbra, Inc. Reports Third Quarter 2026 Financial Results

ALAMEDA, Calif., Oct. 29, 2026 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the third quarter ended September 30, 2026.

PRNewsWire • 6 hours ago

Boston Scientific Warned You. It Slashed Earnings Guidance After Cyberattack Hit Its Business.

Boston Scientific cuts full-year guidance as the medical device maker grapples with the fallout of a cyberattack.

Barrons • Oct 28, 2026

Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact

NYSE · As of 4:00 PM ET 10/28/26

The Motley Fool • Oct 28, 2026

Boston Scientific: 3 Key Takeaways for Long-Term Investors

An eight-day cyber outage reduced third-quarter sales by $150 million. Management expects full-year 2026 organic revenue growth of 4%.

The Motley Fool • a day ago

Boston Scientific Crashes 11% As Cybersecurity Attack Weighs On Guide

Boston Scientific stock crashed Wednesday after the medtech giant cut its 2026 outlook in the wake of a cybersecurity incident in August.

Investors Business Daily • Oct 28, 2026

Boston Scientific warns of tough 2027 on China pricing, heart-device weakness

Boston Scientific warns of tough 2027 on China pricing, heart-device weakness

Reuters • Oct 28, 2026

Boston Scientific Cuts View Again After Cyberattack, Other Challenges

Boston Scientific lowered its outlook, as it expects to end a difficult year with a fourth-quarter sales decline.

WSJ • Oct 28, 2026